Symphion Technology Offers Solution to Saline Shortage for Gynecological Procedures
TL;DR
Minerva Surgical's Symphion technology offers a solution to mitigate the rationing of saline for operative hysteroscopy procedures, giving gynecologists a competitive advantage.
The Symphion Operative Hysteroscopy System conserves saline with a fluid recirculation system and maintains procedural efficiency, using only one bag of saline for uterine polyp or fibroid removal.
Symphion helps healthcare facilities continue to provide relief to patients suffering from Abnormal Uterine Bleeding by addressing the critical saline supply shortage and improving procedural efficiency.
Symphion's fluid recirculation system and innovative features offer a technologically advanced solution for gynecologists navigating the nationwide saline shortage.
Found this article helpful?
Share it with your network and spread the knowledge!

As healthcare facilities across the United States grapple with a nationwide saline shortage, Minerva Surgical's Symphion Operative Hysteroscopy System emerges as a potential solution for gynecologists. The technology's unique fluid recirculation system allows for the use of a single bag of saline during uterine polyp or fibroid removal procedures, addressing the critical need to conserve this essential medical resource.
The saline shortage has led to the reduction or halting of elective procedures in many healthcare facilities. However, the Symphion system's ability to filter and recirculate saline for continuous use during each procedure sets it apart from other uterine tissue removal products that typically require multiple bags of saline. This feature not only conserves saline but may also improve procedural efficiency by eliminating the need to replace depleted saline bags mid-procedure.
Beyond its saline-conserving capabilities, the Symphion system offers several other advantages. It can limit patient exposure to saline fluid absorption below the maximum guidelines set by the American Association of Gynecologic Laparoscopists (AAGL). The system also includes a bipolar RF tissue resecting device for polyp and fibroid removal, a coagulation function for controlling persistent bleeding, and independent on-demand aspiration to maintain visibility during procedures.
The implications of this technology extend beyond immediate resource conservation. By enabling gynecologists to continue performing necessary procedures during the saline shortage, the Symphion system could help maintain access to critical women's health services. This is particularly important for patients suffering from Abnormal Uterine Bleeding (AUB), a condition that can significantly impact quality of life.
Darin Hammers, Minerva Surgical's Chief Executive Officer, emphasized the company's commitment to supporting healthcare providers and patients during this challenging time. The Symphion technology represents a proactive approach to addressing supply chain disruptions in healthcare, potentially setting a precedent for future innovations in medical resource management.
As the healthcare industry continues to navigate supply shortages and resource constraints, technologies like Symphion highlight the importance of adaptive and efficient medical solutions. The ability to maintain essential services in the face of resource limitations could prove crucial in ensuring continuity of care and patient outcomes in women's health and beyond.
Curated from News Direct

